Aquestive Therapeutics, Inc.
AQST
$5.39
$0.316.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 62.70% | 61.29% | 69.36% | 65.69% | -32.64% |
| Total Receivables | -21.39% | -34.25% | 141.87% | 21.86% | 97.80% |
| Inventory | -9.34% | 12.06% | 2.07% | 12.29% | 16.64% |
| Prepaid Expenses | 176.92% | 57.35% | 26.84% | 48.33% | 1.61% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 45.00% | 46.00% | 69.20% | 57.06% | -21.43% |
|
|
|||||
| Total Current Assets | 45.00% | 46.00% | 69.20% | 57.06% | -21.43% |
| Net Property, Plant & Equipment | 35.81% | -6.14% | -5.20% | -5.14% | -6.27% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -46.98% | -37.49% | -37.44% | -24.37% | -24.30% |
| Total Assets | 40.99% | 38.04% | 58.17% | 48.75% | -20.33% |
|
|
|||||
| Total Accounts Payable | -24.99% | -3.18% | 190.29% | 43.49% | 109.81% |
| Total Accrued Expenses | -14.84% | 1.35% | -16.10% | 13.21% | -5.45% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -77.26% | 2,426.10% | 1,882.28% | 1,266.47% | 682.25% |
| Total Finance Division Other Current Liabilities | 0.00% | 2.15% | 2.15% | 2.15% | 2.25% |
| Total Other Current Liabilities | 0.00% | 2.15% | 2.15% | 2.15% | 2.25% |
| Total Current Liabilities | -28.84% | 73.53% | 152.36% | 68.78% | 66.64% |
|
|
|||||
| Total Current Liabilities | -28.84% | 73.53% | 152.36% | 68.78% | 66.64% |
| Long-Term Debt | 59.43% | -25.63% | -15.29% | -4.12% | 6.26% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 58.82% | -14.03% | -12.98% | -12.01% | -11.12% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.95% | 7.40% | 8.91% | 3.64% | 2.58% |
| Total Liabilities | 13.47% | 7.36% | 20.12% | 7.91% | 8.63% |
|
|
|||||
| Common Stock & APIC | 28.81% | 29.45% | 36.39% | 36.67% | 9.34% |
| Retained Earnings | -19.57% | -17.85% | -23.07% | -19.93% | -19.44% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 22.05% | 44.11% | 44.04% | 90.95% | -104.60% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 22.05% | 44.11% | 44.04% | 90.95% | -104.60% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 22.05% | 44.11% | 44.04% | 90.95% | -104.60% |
|
|
|||||